DK2500036T3 - MET-hæmmere til øgning af virkningen af radioterapi - Google Patents

MET-hæmmere til øgning af virkningen af radioterapi

Info

Publication number: DK2500036T3
Authority: DK; Denmark
Prior art keywords: radiotherapy; increase; effect; met inhibitors; inhibitors
Prior art date: 2011-03-18

Application number

DK11158861.2T

Other languages

English (en)

Inventor

Paolo Maria Comoglio

Carla Boccaccio

Fiorella Petronzelli

Santis Rita De

Original Assignee

Metheresis Translational Res Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-03-18

Filing date

2011-03-18

Publication date

2014-08-04

2011-03-18 Application filed by Metheresis Translational Res Sa filed Critical Metheresis Translational Res Sa

2014-08-04 Application granted granted Critical

2014-08-04 Publication of DK2500036T3 publication Critical patent/DK2500036T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

DK11158861.2T 2011-03-18 2011-03-18 MET-hæmmere til øgning af virkningen af radioterapi DK2500036T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP11158861.2A EP2500036B1 (en)	2011-03-18	2011-03-18	MET inhibitors for enhancing radiotherapy efficacy

Publications (1)

Publication Number	Publication Date
DK2500036T3 true DK2500036T3 (da)	2014-08-04

Family

ID=44260211

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK11158861.2T DK2500036T3 (da)	2011-03-18	2011-03-18	MET-hæmmere til øgning af virkningen af radioterapi

Country Status (23)

Country	Link
US (1)	US20120237524A1 (da)
EP (1)	EP2500036B1 (da)
JP (1)	JP5671487B2 (da)
KR (1)	KR101540838B1 (da)
CN (1)	CN102688491A (da)
AU (1)	AU2012201303B2 (da)
BR (1)	BR102012006063B1 (da)
CA (1)	CA2769991C (da)
CY (1)	CY1115374T1 (da)
DK (1)	DK2500036T3 (da)
EA (1)	EA028590B1 (da)
ES (1)	ES2489475T3 (da)
HK (1)	HK1174539A1 (da)
HR (1)	HRP20140729T1 (da)
IL (1)	IL218293A (da)
MX (1)	MX2012003084A (da)
PL (1)	PL2500036T3 (da)
PT (1)	PT2500036E (da)
RS (1)	RS53468B (da)
SG (1)	SG184637A1 (da)
SI (1)	SI2500036T1 (da)
SM (1)	SMT201400106B (da)
ZA (1)	ZA201201992B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9168300B2 (en)	2013-03-14	2015-10-27	Oncomed Pharmaceuticals, Inc.	MET-binding agents and uses thereof
TWI782930B (zh)	2016-11-16	2022-11-11	美商再生元醫藥公司	抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
CN110320365B (zh) *	2019-07-06	2022-07-22	湖南莱拓福生物科技有限公司	NF-κB RelA/p65蛋白位点特异性磷酸化诊断试剂盒
EP4031574A1 (en)	2019-09-16	2022-07-27	Regeneron Pharmaceuticals, Inc.	Radiolabeled met binding proteins for immuno-pet imaging

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI310684B (en) *	2000-03-27	2009-06-11	Bristol Myers Squibb Co	Synergistic pharmaceutical kits for treating cancer
MXPA05008521A (es) *	2003-02-13	2005-10-20	Pharmacia Corp	Anticuerpos a c-met para el tratamiento de canceres.
JP5105874B2 (ja) *	2003-07-18	2012-12-26	アムジエン・インコーポレーテツド	肝細胞増殖因子に対する特異的結合因子
HN2004000285A (es) *	2003-08-04	2006-04-27	Pfizer Prod Inc	ANTICUERPOS DIRIGIDOS A c-MET
CA2638889C (en) *	2006-02-06	2015-06-02	Metheresis Translational Research S.A.	Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products
EP2019116A1 (en) *	2007-07-26	2009-01-28	Helmholtz-Zentrum für Infektionsforschung GmbH	Inhibitor of the met-receptor and its use

2011
- 2011-03-18 DK DK11158861.2T patent/DK2500036T3/da active
- 2011-03-18 EP EP11158861.2A patent/EP2500036B1/en active Active
- 2011-03-18 ES ES11158861.2T patent/ES2489475T3/es active Active
- 2011-03-18 PT PT111588612T patent/PT2500036E/pt unknown
- 2011-03-18 RS RS20140404A patent/RS53468B/en unknown
- 2011-03-18 SI SI201130217T patent/SI2500036T1/sl unknown
- 2011-03-18 PL PL11158861T patent/PL2500036T3/pl unknown
2012
- 2012-02-22 SG SG2012012514A patent/SG184637A1/en unknown
- 2012-02-23 IL IL218293A patent/IL218293A/en active IP Right Grant
- 2012-02-24 JP JP2012039193A patent/JP5671487B2/ja active Active
- 2012-03-01 CA CA2769991A patent/CA2769991C/en active Active
- 2012-03-02 AU AU2012201303A patent/AU2012201303B2/en active Active
- 2012-03-13 MX MX2012003084A patent/MX2012003084A/es active IP Right Grant
- 2012-03-13 KR KR1020120025311A patent/KR101540838B1/ko active IP Right Grant
- 2012-03-16 CN CN2012100803665A patent/CN102688491A/zh active Pending
- 2012-03-16 EA EA201200329A patent/EA028590B1/ru not_active IP Right Cessation
- 2012-03-16 ZA ZA2012/01992A patent/ZA201201992B/en unknown
- 2012-03-16 BR BR102012006063-9A patent/BR102012006063B1/pt active IP Right Grant
- 2012-03-19 US US13/423,830 patent/US20120237524A1/en not_active Abandoned
2013
- 2013-02-01 HK HK13101476.6A patent/HK1174539A1/xx unknown
2014
- 2014-07-24 CY CY20141100561T patent/CY1115374T1/el unknown
- 2014-07-29 HR HRP20140729AT patent/HRP20140729T1/hr unknown
- 2014-07-31 SM SM201400106T patent/SMT201400106B/xx unknown

Also Published As

Publication number	Publication date
EA201200329A2 (ru)	2012-09-28
IL218293A (en)	2016-06-30
JP5671487B2 (ja)	2015-02-18
EP2500036B1 (en)	2014-05-07
BR102012006063A8 (pt)	2022-11-08
HRP20140729T1 (hr)	2014-08-29
MX2012003084A (es)	2012-09-17
CA2769991A1 (en)	2012-09-18
KR20120106582A (ko)	2012-09-26
SG184637A1 (en)	2012-10-30
EP2500036A1 (en)	2012-09-19
AU2012201303B2 (en)	2013-11-07
ZA201201992B (en)	2015-05-27
CA2769991C (en)	2018-05-15
KR101540838B1 (ko)	2015-08-06
BR102012006063B1 (pt)	2023-03-07
CY1115374T1 (el)	2017-01-04
SMT201400106B (it)	2014-11-10
JP2012196206A (ja)	2012-10-18
SI2500036T1 (sl)	2014-09-30
AU2012201303A1 (en)	2012-10-04
ES2489475T3 (es)	2014-09-02
EA028590B1 (ru)	2017-12-29
PL2500036T3 (pl)	2014-10-31
BR102012006063A2 (pt)	2021-11-16
US20120237524A1 (en)	2012-09-20
EA201200329A3 (ru)	2013-01-30
CN102688491A (zh)	2012-09-26
HK1174539A1 (en)	2013-06-14
IL218293A0 (en)	2012-07-31
PT2500036E (pt)	2014-08-25
RS53468B (en)	2014-12-31

Publication	Publication Date	Title
SMT201700109B (it)	2017-03-08	Inibitori di istone demetilasi
SMT201700111B (it)	2017-03-08	Eterociclilammine come inibitori di pi3k
SMT201700094B (it)	2017-03-08	Composto di pirazina carbossammide
CO7010824A2 (es)	2014-07-31	Inhibidores de aplicación viral
CO6930358A2 (es)	2014-04-28	Compuestos inhibidores de metaloenzimas
CO6920291A2 (es)	2014-04-10	3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idhmutante
DK3520805T3 (da)	2021-04-19	Sammensætninger til behandling af myelofibrose
DK2804858T3 (da)	2020-03-16	Metalloenzym-inhibitorforbindelser
SMT201600328B (it)	2016-11-10	Nuovi composti come inibitori di diacilglicerolo aciltransferasi
DK2755481T3 (da)	2020-06-15	Anvendelse af alginatoligomerer til at forøge virkningerne af svampemidler
SMT201600001B (it)	2016-02-25	Imidazopiridazine come inibitori di akt chinasi
BR112014013850A2 (pt)	2017-06-13	conjunto de prateleiras
DK2800572T3 (da)	2017-11-20	Sammensætning af ellagitannin-rige ekstrakter
BR112013028029A2 (pt)	2017-08-08	composto
DK2928477T3 (da)	2019-10-07	Anvendelse af telomeraseinhibitor imetelstat til behandling af myelofibrosis
DK2888228T3 (da)	2019-07-15	Inhibitorer af CD40-TRAF6 interaktion
DK2500036T3 (da)	2014-08-04	MET-hæmmere til øgning af virkningen af radioterapi
CR20130603A (es)	2014-09-09	Compuestos novedosos como inhibidores de diacilglicerol
BR112014015607A2 (pt)	2017-06-13	composto
BR112013032866A2 (pt)	2017-01-24	composto
FR2997080B1 (fr)	2015-11-27	Inhibiteurs de neprilysine
FR2973705B1 (fr)	2013-08-02	Inhibiteur de tnf-alpha.
UA22461S (uk)	2011-11-25	Деталь фасонна компресійна-цанга
UA22462S (uk)	2011-11-25	Деталь фасонна компресійна-фланець
UA22681S (uk)	2012-01-25	Комплект напрямних для меблів